You are here

NEUGENESIS CORPORATION

Company Information
Address
NEUGENESIS CORPORATION 871 INDUSTRIAL RD, STE J
SAN CARLOS, CA 94070
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. GENE DIVERSIFICATION BY DIRECTED RETROTRANSPOSITION

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Gene-products of recombinant origin have substantial commercial value for pharmaceutical and technical uses. Directed evolution approaches to genera ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  2. PRODUCTION OF RECOMBINANT PROTEINS IN NEUROSPORA CRASSA

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  3. RAPID APPROACHES FOR PRODUCTION OF GENOMIC DNA PROBES

    Amount: $332,000.00

    CURRENT METHODS TO ISOLATE CLUSTERS OF DNA FRAGMENTS LINKED TO A GIVEN MARKER ARE SLOW AND CUMBERSOME. METHODS FOR IN SITU HYBRIDIZATION OF UNIQUE' COPY GENE SEQUENCES TO HUMAN CHROMOSOMES ARE ALSO DI ...

    SBIRPhase II1987Department of Health and Human Services
  4. NEW APPROACHES TO PRODUCTION OF HLA TYPING REAGENTS

    Amount: $495,000.00

    HUMAN CLASS II HISTOCOMPATIBILITY ANTIGEN TYPING IS ALREADY OF SUBSTANTIAL IMPORTANCE IN DETERMING DISEASE SUSCEPTIBILITY IN INDIVIDUALS. PRESENT SEROLOGIC METHODS OF CLASS II ANTIGEN TYPING ARE LIMIT ...

    SBIRPhase II1986Department of Health and Human Services
  5. HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

    Amount: $500,000.00

    THE IMMUNE RESPONSE IN MAN IS REGULATED BY ORDERED INTERACTIONS BETWEEN FUNCTIONALLY AND PHENOTYPICALLY DISTINCT LYMPHOID CELLS (T CELLS AND THEIR SUBSETS, B CELLS AND MONOCYTES) IN THE CONTEXT OF IA- ...

    SBIRPhase II1986Department of Health and Human Services
  6. UNTIL VERY RECENTLY, THE SIZES OF DNA FRAGMENTS THAT COULD BE DEALT WITH BY CLONING AND ELECTROPHORETIC TECHNIQUES WEREGENERALLY ONE TO TWO ORDERS OF MAGNITUDE BELOW THOSE NEEDED FOR A PRACTICAL AND SYSTEMATIC MOLECULAR DESCRIPTION OF HUMAN DNA

    Amount: $50,000.00

    UNTIL VERY RECENTLY, THE SIZES OF DNA FRAGMENTS THAT COULD BE DEALT WITH BY CLONING AND ELECTROPHORETIC TECHNIQUES WEREGENERALLY ONE TO TWO ORDERS OF MAGNITUDE BELOW THOSE NEEDED FOR A PRACTICAL AND S ...

    SBIRPhase I1986Department of Health and Human Services
  7. MONOCLONAL ANTIBODIES TO HTLV-III/LAV

    Amount: $50,000.00

    MOUSE AND RAT MONOCLONAL ANTIBODIES WILL BE PRODUCED AGAINSTHTLV-III, THE HUMAN RETROVIRUS ASSOCIATED WITH AIDS AND A SPECTRUM OF RELATED SYNDROMES. GENE LABS WILL EMPLOY INTACTHTLV-III VIRIONS COUPLE ...

    SBIRPhase I1986Department of Health and Human Services
  8. IN THIS PROJECT, GENE LABS, INC.

    Amount: $50,000.00

    IN THIS PROJECT, GENE LABS, INC. WILL PRODUCE AND CHARACTERIZE HUMAN MONOCLONAL ANTIBODIES TO HTLV-III, THE HUMAN RETROVIRUS ASSOCIATED WITH AIDS AND A SPECTRUM OF RELATED SYNDROMES. GENE LABS HAS SUC ...

    SBIRPhase I1986Department of Health and Human Services
  9. THE GOAL OF THIS PROPOSED RESEARCH IS TO DEFINE THE MOLECU- LAR STRUCTURES THAT DETERMINE THE ANTIGENETIC REACTIVITY OF THE HUMAN RH SYSTEM.

    Amount: $50,000.00

    THE GOAL OF THIS PROPOSED RESEARCH IS TO DEFINE THE MOLECU- LAR STRUCTURES THAT DETERMINE THE ANTIGENETIC REACTIVITY OF THE HUMAN RH SYSTEM. USING PREEXISTING HUMAN MONOCLONAL ANTIBODIES DIRECTED AGAI ...

    SBIRPhase I1986Department of Health and Human Services
  10. THEIR POTENTIAL APPLICATIONS TO A SUBUNIT VACCINE

    Amount: $50,000.00

    HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE I (HTLV-I) IS THE CAUSATIVE AGENT OF AN AGGRESSIVE FORM OF T-CELL LEUKEMIA ENDEMIC TO CERTAIN GEOGRAPHIC AREAS BUT ALSO CURRENTLY INCREASING IN FREQUENCY IN THE S ...

    SBIRPhase I1986Department of Health and Human Services
US Flag An Official Website of the United States Government